Aspire Biopharma Holdings, Inc. — SCHEDULE 13G/A Filings
10 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Aspire Biopharma Holdings, Inc. (ASBPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aspire Biopharma Holdings, Inc. has filed 10 SCHEDULE 13G/A documents with the SEC since 2021. To view all SEC filings by Aspire Biopharma Holdings, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-4
S-4/A
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001641172-25-011555 | May 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-072232 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-009072 | May 7, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-005902 | Apr 23, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-005239 | Apr 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-003869 | Apr 11, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-002839 | Apr 4, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-001328 | Mar 28, 2025 | — |
| SCHEDULE 13G/A | — | 0001641172-25-000116 | Mar 20, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-010043 | Mar 12, 2025 | — |